Skip to main content

Warnex Receives DEQAS Certification for Vitamin D Testing

NEW YORK (GenomeWeb News) – Warnex today announced its Bioanalytical Services division participated in the International External Quality Assessment Scheme, or DEQAS, and received DEQAS certification for the analysis of Vitamin D (25-hydroxyvitamin D.)

Analysis of 25-hydroxyvitamin D is one of the most accurate testing methods of Vitamin D in the body, Warnex said, and its participation in DEQAS demonstrated the reliability of its method in terms of absolute values, assay linearity, and assay precision. Warnex's method of analysis combines high-performance liquid chromatography and mass spectrometry to measure 25-hydroxyvitamin D2 and D3 in plasma.

Vitamin D deficiency has been linked to rickets in children and osteomalacia and osteoporosis in adults, as well as certain cancers, type 1 diabetes, Alzheimer's, and other illnesses.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.